Transcatheter atrial septal defect closure with the Das™ angel wings transcatheter ASD occlusion device: The Cincinnati-Rochester experience

Alan M. Mendelsohn; Anirban Banerjee; David C. Schwartz; Gladwin S. Das

doi:10.1111/j.1540-8183.1998.tb00152.x

Transcatheter atrial septal defect closure with the Das™ angel wings transcatheter ASD occlusion device: The Cincinnati-Rochester experience

Alan M. Mendelsohn, Anirban Banerjee, David C. Schwartz, Gladwin S. Das

Medicine - Cardiology Division

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

The Angel Wings Das device, a recently developed transcatheter atrial septal defect occluder, represents a new approach to therapy of this congenital cardiac lesion. Overall, successful defect occlusion occurs in > 90% of patients following device implantation. We describe the major design and technical issues pertinent to this device and review both international and personal local FDA Phase I trial results and complications. Future trial plans and device modifications are discussed.

Original language	English (US)
Pages (from-to)	495-500
Number of pages	6
Journal	Journal of Interventional Cardiology
Volume	11
Issue number	5 I
DOIs	https://doi.org/10.1111/j.1540-8183.1998.tb00152.x
State	Published - Oct 1998

Publisher link

10.1111/j.1540-8183.1998.tb00152.x

Find It

Find It at U of M Libraries

Cite this

@article{11e583edd6004f48b98855c818670dcf,

title = "Transcatheter atrial septal defect closure with the Das{\texttrademark} angel wings transcatheter ASD occlusion device: The Cincinnati-Rochester experience",

abstract = "The Angel Wings Das device, a recently developed transcatheter atrial septal defect occluder, represents a new approach to therapy of this congenital cardiac lesion. Overall, successful defect occlusion occurs in > 90% of patients following device implantation. We describe the major design and technical issues pertinent to this device and review both international and personal local FDA Phase I trial results and complications. Future trial plans and device modifications are discussed.",

author = "Mendelsohn, {Alan M.} and Anirban Banerjee and Schwartz, {David C.} and Das, {Gladwin S.}",

year = "1998",

month = oct,

doi = "10.1111/j.1540-8183.1998.tb00152.x",

language = "English (US)",

volume = "11",

pages = "495--500",

journal = "Journal of Interventional Cardiology",

issn = "0896-4327",

publisher = "John Wiley and Sons Inc",

number = "5 I",

}

TY - JOUR

T1 - Transcatheter atrial septal defect closure with the Das™ angel wings transcatheter ASD occlusion device

T2 - The Cincinnati-Rochester experience

AU - Mendelsohn, Alan M.

AU - Banerjee, Anirban

AU - Schwartz, David C.

AU - Das, Gladwin S.

PY - 1998/10

Y1 - 1998/10

N2 - The Angel Wings Das device, a recently developed transcatheter atrial septal defect occluder, represents a new approach to therapy of this congenital cardiac lesion. Overall, successful defect occlusion occurs in > 90% of patients following device implantation. We describe the major design and technical issues pertinent to this device and review both international and personal local FDA Phase I trial results and complications. Future trial plans and device modifications are discussed.

AB - The Angel Wings Das device, a recently developed transcatheter atrial septal defect occluder, represents a new approach to therapy of this congenital cardiac lesion. Overall, successful defect occlusion occurs in > 90% of patients following device implantation. We describe the major design and technical issues pertinent to this device and review both international and personal local FDA Phase I trial results and complications. Future trial plans and device modifications are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0031742711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031742711&partnerID=8YFLogxK

U2 - 10.1111/j.1540-8183.1998.tb00152.x

DO - 10.1111/j.1540-8183.1998.tb00152.x

M3 - Article

AN - SCOPUS:0031742711

SN - 0896-4327

VL - 11

SP - 495

EP - 500

JO - Journal of Interventional Cardiology

JF - Journal of Interventional Cardiology

IS - 5 I

ER -

Transcatheter atrial septal defect closure with the Das™ angel wings transcatheter ASD occlusion device: The Cincinnati-Rochester experience

Abstract

Publisher link

Find It

Other files and links

Fingerprint

Cite this